PharmChem PE Ratio 2023-2024 | PCHM
Current and historical p/e ratio for PharmChem (PCHM) from 2023 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. PharmChem PE ratio as of May 02, 2025 is 10.33.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| PharmChem PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2025-05-01 |
3.00 |
|
10.33 |
| 2024-12-31 |
3.06 |
$0.29 |
10.55 |
| 2024-09-30 |
3.14 |
$0.29 |
10.81 |
| 2024-06-30 |
3.40 |
$0.25 |
13.59 |
| 2024-03-31 |
2.48 |
$0.17 |
14.56 |
| 2023-12-31 |
2.42 |
$0.17 |
14.23 |
| 2023-09-30 |
2.43 |
$0.15 |
16.19 |
| 2023-06-30 |
2.37 |
$0.15 |
15.82 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-OUTP/HM CRE |
$0.014B |
$0.006B |
|
PharmChem is an independent laboratory providing integrated drug testing services on a national basis to corporate and governmental clients seeking to detect and deter the use of illegal drugs. PharmChem operates a certified forensic drug-testing laboratory in Haltom City, Texas.
|
